Content Author: Kerri Virani
Current Owner: Health promotion
HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy, Mujugira A1, Celum C, Coombs RW, Campbell JD, Ndase P, Ronald A, Were E, Bukusi EA, Mugo N, Kiarie J, Baeten JM; Partners PrEP Study Team
National Center for Biotechnology Information
US National Library of Medicine
2016 Aug 15;72(5):579-84. doi: 10.1097/QAI.0000000000001019
HIV treatment as prevention and HPTN 052, Cohen MS1, McCauley M, Gamble TR
National Center for Boiotechnology Information
US National Library of Medicine
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy, Journal of the American Medical Association: Alison J. Rodger, MD; Valentina Cambiano, PhD; Tina Bruun, RN; Pietro Vernazza, MD; Simon Collins; Jan van Lunzen, PhD; Giulio Maria Corbelli; Vicente Estrada, MD; Anna Maria Geretti, MD; Apostolos Beloukas, PhD; David Asboe, FRCP; Pompeyo Viciana, MD1; Félix Gutiérrez, MD; Bonaventura Clotet, PhD; Christian Pradier, MD; Jan Gerstoft, MD; Rainer Weber, MD; Katarina Westling, MD; Gilles Wandeler, MD; Jan M. Prins, PhD; Armin Rieger, MD; Marcel Stoeckle, MD; Tim Kümmerle, PhD; Teresa Bini, MD; Adriana Ammassari, MD; Richard Gilson, MD; Ivanka Krznaric, PhD; Matti Ristola, PhD; Robert Zangerle, MD; Pia Handberg, RN; Antonio Antela, PhD; Sris Allan, FRCP; Andrew N. Phillips, PhD; Jens Lundgren, MD, JAMA. 2016;316(2):171-181. doi:10.1001/jama.2016.5148
Viral load, Michael Carter, Greta Hughson, NAM, Aidsmap, March 2014
More confidence on zero risk: still no transmissions seen from people with an undetectable viral load in PARTNER study, Gus Cairns, NAM, Aidsmap, July 2016
Pragmatic Open-Label Randomised Trial of Pre-Exposure Prophylaxis: the PROUD study, PROUD, MRC Clinical Trials Unit & Public Health England, February 2015
PROUD study interim analysis finds pre-exposure prophylaxis (PrEP) is highly protective against HIV for gay men and other men who have sex with men in the UK, PROUD, MRC Clinical Trials Unit & Public Health England, October 2014
Viral load and transmission - a factsheet for HIV negative people, by Gus Cairns, NAM, Aidsmap, 16/9/15
Viral load and transmission – a factsheet for people with HIV, by Gus Cairns 16/9/15, NAM, Aidsmap
Is there a cure for HIV and AIDS?, Avert, 1/5/15
Early antiretroviral treatment reduces but does not eliminate HIV reservoir, by Liz Highleyman, NAM, Aidsmap, 24/3/15
What are normal ranges for a CD4 count, the CD4% and the CD4:CD8 ratio?, by Simon Collins, iBase, 19/9/14
How HIV destroys the immune cells, by Dan Cossins, The Scientist, 19/12/13
CD4 cell counts, NAM, Aidsmap, February 2012
The basics - CD4 and viral load booklet, NAM, Aidsmap, February 2012
Adherence, by Michael Carter & Greta Hughson, NAM, Aidsmap, 31/3/12
What does taking your HIV treatment involve?, NAM, Aidsmap, March 2014
Aids info - Education materials - Viral rebound
Common side effects - From Side Effects booklet, NAM, Aidsmap, July 2013
Changing treatment due to side effects, by Michael Carter & Greta Hughson, NAM, Aidsmap, 31/3/12
Monitoring the safety and effectiveness of HIV treatment - From Taking Your HIV Treatment booklet, NAM, Aidsmap, March 2014
How long will I live if I stop taking my HIV medication? - Question answered by Angelina Namiba, iBase, 19/1/12
Prognosis, by Michael Carter & Greta Hughson, NAM, Aidsmap, 13/3/12
HIV basics - What is the life expectancy of someone with HIV?, NAM, Aidsmap
Is treatment prevention?, NAM, Aidsmap
No one with an undetectable viral load – gay or heterosexual – transmits HIV in first two years of PARTNER study, NAM, Aidsmap
BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015, Writing Group: Duncan Churchill Chair Laura Waters Vice Chair N Ahmed, B Angus, M Boffito, M Bower, D Dunn, S Edwards, C Emerson, S Fidler, †M Fisher, R Horne, S Khoo, C Leen, N Mackie, N Marshall, F Monteiro, M Nelson, C Orkin, A Palfreeman, S Pett, A Phillips, F Post, A Pozniak, I Reeves, C Sabin, R Trevelion, J Walsh, E Wilkins, I Williams, A Winston
START trial finds that early treatment improves outcomes for people with HIV, NAM, Aidsmap, Gus Cairns, 27/5/15
START trial provides definitive evidence of the benefits of early HIV treatment, NAM, Aidsmap, Liz Highleyman; Produced in collaboration with hivandhepatitis.com, 21/7/15
Your treatment. NAM.
HIV Basic Treatment. NAM.
Anti-HIV drugs. NAM.
Progression to AIDS or death. NAM.
People doing well on HIV therapy have a mortality risk identical to that of HIV-negative peers. NAM.
Decrease in AIDS-related illness and deaths. NAM.
Link with reduced infectiousness and good adherence. BHIVA.